Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE L'EUROPE : revenue, balance sheet and financial ratios

PHARMACIE DE L'EUROPE is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SENS (89100), this company of category PME shows in 2024 a net income positive of 265 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE L'EUROPE (SIREN 493474001)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 265 400 € 67 904 € -338 557 € 175 546 € 238 200 € 182 420 € 257 967 € 281 946 € 243 839 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE DE L'EUROPE generates positive net income of 265 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 244 k€ -> 265 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

265 400 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

44.858%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.072%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

11.1%

Solvency indicators evolution
PHARMACIE DE L'EUROPE

Sector positioning

Debt ratio
44.86 2024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good -15 pts over 3 years

In 2024, the debt ratio of PHARMACIE DE L'EUROPE (44.86) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
60.07% 2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good +22 pts over 3 years

In 2024, the financial autonomy of PHARMACIE DE L'EUROPE (60.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 163.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

163.417

Liquidity indicators evolution
PHARMACIE DE L'EUROPE

Sector positioning

Liquidity ratio
163.42 2024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average

In 2024, the liquidity ratio of PHARMACIE DE L'EUROPE (163.42) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMACIE DE L'EUROPE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE L'EUROPE is estimated at 3 705 180 € (range 2 580 228€ - 5 543 161€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2580k€ 3705k€ 5543k€
3 705 180 € Range: 2 580 228€ - 5 543 161€
NAF 5 année 2024

Valuation method used

Net Income Multiple
265 400 € × 14.0x = 3 705 180 €
Range: 2 580 229€ - 5 543 162€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE L'EUROPE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE L'EUROPE

What is the revenue of PHARMACIE DE L'EUROPE ?

The revenue of PHARMACIE DE L'EUROPE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE L'EUROPE profitable?

Yes, PHARMACIE DE L'EUROPE generated a net profit of 265 k€ in 2024.

Where is the headquarters of PHARMACIE DE L'EUROPE ?

The headquarters of PHARMACIE DE L'EUROPE is located in SENS (89100), in the department Yonne.

Where to find the tax return of PHARMACIE DE L'EUROPE ?

The tax return of PHARMACIE DE L'EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE L'EUROPE operate?

PHARMACIE DE L'EUROPE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.